Concepedia

Hilda Kennedy

HK

Statistics

Publications

4

Citations

211

H-Index

4

Active since

2011

Affiliations

University of Nottingham(Current)

Zhengzhou University

Nottingham University Hospitals NHS Trust

Baylor College of Medicine

Hilda Kennedy is an author at University of Nottingham specializing in oncology, breast cancer prognosis, and breast cancer surgery.

ORCID

Publications per year

2011–2022

4

Publications

4

Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer

Meenakshi Anurag, Jonathan T. Lei, Jin Cao et al. · Cancer Cell · 2020 · 107 citations · Full text

, , +17

Long-term clinical outcome of oestrogen receptor-positive operable primary breast cancer in older women: a large series from a single centre

Binafsha Manzoor Syed, Waleed Al‐Khyatt, Simon J. Johnston et al. · British Journal of Cancer · 2011 · 51 citations · Full text

, , +16

Long-term (37 years) clinical outcome of older women with early operable primary breast cancer managed in a dedicated clinic

Binafsha Manzoor Syed, Simon J. Johnston, D. W. M. Wong et al. · Annals of Oncology · 2011 · 32 citations

, , +14

Elevated NRAS expression during DCIS is a potential driver for progression to basal-like properties and local invasiveness

Hanan S. Elsarraj, Jonathan T. Lei, Hong Yan et al. · Breast Cancer Research · 2022 · 21 citations · Full text

, , +17

1–4 of 4